Displaying 101 - 120 of 1549
FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Â鶹´«Ã½
FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop
Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd.
FTC Proposes Amendments to Strengthen and Modernize the Health Breach Notification Rule
Ovulation Tracking App Premom Will be Barred from Sharing Health Data for Advertising Under Proposed FTC Order
FTC Deepens Inquiry into Prescription Drug Middlemen
Amgen Inc. and Horizon Therapeutics plc, FTC v.
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
FTC Releases Agenda for May 18 Workshop on Proposed Changes to the Eyeglass Rule
FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Â鶹´«Ã½ Reporting Law
FTC Sends 37 New Cease and Desist Letters Regarding Agency’s Eyeglass Rule
FTC Approves Final Order against The Bountiful Company in First Case Alleging Hijacking of Online Product Reviews
Public Workshop Examining Proposed Changes to the Ophthalmic Practice Rules (Eyeglass Rule)
FTC to Host Public Workshop on Proposed Changes to Its Ophthalmic Practice Rules, also Known as the Eyeglass Rule, in May in Washington, DC
Dalal A. Akoury d/b/a AWAREmed, et al., U.S. v.
In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act, suing Dr. Dalal A. Akoury and a set of companies she controls that operate as AWAREmed Health & Wellness Resource Center, a medical clinic, for making a wide range of false or unsupported claims for addiction treatment services, cancer treatment services, and the treatment of other serious conditions. The proposed order settling the Commission’s complaint bars Dr. Akoury and her AWAREmed clinic from making such unsupported claims and requires her to pay a $100,000 civil penalty.
FTC Approves Final Order against LCA-Vision, Halting Alleged Bait-and-Switch Advertising for LASIK Laser Eye Surgery
Displaying 101 - 120 of 1549